AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Leo Cancer Care has raised $65M in a Series D round led by Yu Galaxy, aiming to enhance its integrated upright cancer care platform and accelerate its commercial deployment.
Leo Cancer Care announced the close of an oversubscribed $65 million Series D financing round. Led by Yu Galaxy, the investment will support manufacturing and commercial deployment of its upright cancer care platform. Continued clinical and product development is also a focus. This financing follows the world’s first compact upright proton treatment at Stanford Medicine.
Company Information
Company
Leo Cancer Care
Location
Surrey, England, United Kingdom
About
Leo Cancer Care is a company dedicated to delivering radiation therapy in a more human way. Their unique upright patient positioning and CT imaging system, named Marie®, offers a gantry-less approach and aims to reduce internal organ movement in patients receiving upright therapy. The company aims to expand its global footprint and is dedicated to providing more personalized care for cancer patients.
Fundz sees it the moment Leo Cancer Care raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
SurreyBiotechnologyHealth CareMedicalMedical Device